"id:ID","uuid","description","label","instanceType","name","id","text"
"758","ea189bed-2eaa-4ff9-93fe-aa00726580cf","Main objective","","OBJECTIVE","OBJ1","Objective_1","To determine if there is a statistically significant relationship (overall Type 1 erroralpha=0.05) between the change in both the ADAS-Cog (11) and CIBIC+ scores, and drug dose (0, 50 cm2 [54 mg], and 75 cm2 [81 mg])."
"759","1948c376-c55d-47ec-a8e6-1193cb58515e","Safety","","OBJECTIVE","OBJ2","Objective_2","To document the safety profile of the xanomeline TTS."
"760","3d7b9a0c-95c9-4e3f-8f75-9cd0adc98f93","Behaviour","","OBJECTIVE","OBJ3","Objective_3","To assess the dose-dependent improvement in behavior. Improved scores on the Revised Neuropsychiatric Inventory (NPI-X) will indicate improvement in these
areas."
